163 related articles for article (PubMed ID: 22226191)
1. The PFA-100 ® does not predict delta-granule platelet storage pool deficiencies.
Sladky JL; Klima J; Grooms L; Kerlin BA; O'Brien SH
Haemophilia; 2012 Jul; 18(4):626-9. PubMed ID: 22226191
[TBL] [Abstract][Full Text] [Related]
2. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
3. Light Transmission Aggregometry Does Not Correlate With the Severity of δ-Granule Platelet Storage Pool Deficiency.
Woods GM; Kudron EL; Davis K; Stanek J; Kerlin BA; O'Brien SH
J Pediatr Hematol Oncol; 2016 Oct; 38(7):525-8. PubMed ID: 27403770
[TBL] [Abstract][Full Text] [Related]
4. ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders.
Alhaj D; Hagedorn N; Cuntz F; Reschke M; Schuldes J; Ruthenberg J; Bakchoul T; Greinacher A; Holzhauer S
Eur J Haematol; 2024 Jul; 113(1):54-65. PubMed ID: 38549165
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
[TBL] [Abstract][Full Text] [Related]
6. The platelet function analyzer (PFA-100): an update on its clinical use.
Franchini M
Clin Lab; 2005; 51(7-8):367-72. PubMed ID: 16122146
[TBL] [Abstract][Full Text] [Related]
7. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis.
Karger R; Donner-Banzhoff N; Müller HH; Kretschmer V; Hunink M
Platelets; 2007 Jun; 18(4):249-60. PubMed ID: 17538845
[TBL] [Abstract][Full Text] [Related]
9. Assessment of platelet adhesiveness and aggregation in mild acute pancreatitis using the PFA-100 system.
Mimidis K; Papadopoulos V; Kartasis Z; Baka M; Tsatlidis V; Bourikas G; Kartalis G
JOP; 2004 May; 5(3):132-7. PubMed ID: 15138334
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
[TBL] [Abstract][Full Text] [Related]
11. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
[TBL] [Abstract][Full Text] [Related]
12. Use of the platelet function analyzer to minimize bleeding complications after renal biopsy.
van den Hoogen MW; Verbruggen BW; Polenewen R; Hilbrands LB; Nováková IR
Thromb Res; 2009; 123(3):515-22. PubMed ID: 18703219
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion.
Cattaneo M; Lecchi A; Agati B; Lombardi R; Zighetti ML
Thromb Res; 1999 Nov; 96(3):213-7. PubMed ID: 10588464
[TBL] [Abstract][Full Text] [Related]
14. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice.
Posan E; McBane RD; Grill DE; Motsko CL; Nichols WL
Thromb Haemost; 2003 Sep; 90(3):483-90. PubMed ID: 12958618
[TBL] [Abstract][Full Text] [Related]
15. The power of a standardized bleeding score in diagnosing paediatric type 1 von Willebrand's disease and platelet function defects.
Marcus PD; Nire KG; Grooms L; Klima J; O'Brien SH
Haemophilia; 2011 Mar; 17(2):223-7. PubMed ID: 20860605
[TBL] [Abstract][Full Text] [Related]
16. [New in vitro analysis tested: bleeding time is still the best method for evaluation of primary hemostasis].
Ridefelt P; Egberg N; Hillarp A; Lethagen S; Tengborn L
Lakartidningen; 2001 Sep; 98(37):3922-4. PubMed ID: 11586831
[TBL] [Abstract][Full Text] [Related]
17. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.
Rand ML; Carcao MD; Blanchette VS
Semin Thromb Hemost; 1998; 24(6):523-9. PubMed ID: 10066147
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
19. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults.
Harrison P
Br J Haematol; 2005 Jul; 130(1):3-10. PubMed ID: 15982339
[TBL] [Abstract][Full Text] [Related]
20. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
